ConductScience.org, home

Paper7034992

Lasting improvement of renovascular hypertension by transluminal dilatation of atherosclerotic and nonatherosclerotic renal artery stenoses. A follow-up study.

Mahler F and 4 others. Circulation, 1982. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. Lasting improvement of renovascular hypertension by transluminal dilatation of atherosclerotic and nonatherosclerotic renal artery stenoses. A follow-up study. Papers, record 7034992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7034992

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lasting improvement of renovascular hypertension by transluminal dilatation of atherosclerotic and nonatherosclerotic renal artery stenoses. A follow-up study.
PubMed
Journal
Circulation
PubMed
Year
1982
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
4.62
iCite
Revised in PubMed
2019-06-23
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mahler FF
2Probst PP
3Haertel MM
4Weidmann PP
5Krneta AA

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ArteriosclerosisMajor topic
Hypertension, RenalMajor topic
Hypertension, RenovascularMajor topic
Renal Artery ObstructionMajor topic
Adult
Blood Pressure
Dilatation
Female
Fibromuscular Dysplasia
Follow-Up Studies
Humans
Male
Middle Aged
Postoperative Complications
Radiography
Renal Circulation
Renin
Vasculitis

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
10928505Tandem stenting of crossed renal arteries with ostial stenosis.Tex Heart Inst J2000https://conductscience.org/library/papers/10928505PubMed
9227378Renovascular disease: the fifth frontier.J R Soc Med1997https://conductscience.org/library/papers/9227378PubMed
6230452Indications for renal artery surgery: a review.J R Soc Med1984https://conductscience.org/library/papers/6230452PubMed
6224140Failure of balloon dilatation in mid-cavity obstruction of the systemic venous atrium after the Mustard operation.Pediatr Cardiol1983https://conductscience.org/library/papers/6224140PubMed
2945963[Transluminal dilatation and other nonsurgical catheter technics in the treatment of renovascular hypertension].Klin Wochenschr1986https://conductscience.org/library/papers/2945963PubMed
2140294Percutaneous transluminal renal angioplasty: initial results and long-term follow-up in 202 patients.Cardiovasc Intervent Radiol1990https://conductscience.org/library/papers/2140294PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7034992

GET https://conductscience.org/api/papers/v1/7034992/authors